ArticleJournal of medical biochemistry2026
Association between vagus nerve cross-sectional area measured by ultrasound and inflammatory biomarkers in hospitalised patients with COVID-19.
Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The vagus nerve plays an important role in neuroimmune communication. This study aimed to examine whether systemic inflammatory biomarkers are associated with ultrasound-measured cross-sectional area (CSA) of the vagus nerve in hospitalised patients with COVID-19. Methods: In this cross-sectional study, 68 hospitalised adults with PCR-confirmed SARS-CoV-2 infection underwent bilateral ultrasound assessment of vagus nerve CSA. For each nerve, CSA was calculated as the mean of three measurements. Serum levels of C-reactive protein (CRP), fibrinogen, and ferritin were recorded. CSA values and inflammatory biomarkers were classified as within or outside predefined reference ranges. Binary logistic regression was used to assess associations between inflammatory biomarkers and vagus nerve CSA classified as outside the reference range. Receiver operating characteristic (ROC) analysis was performed. As a secondary exploratory analysis, a multilayer perceptron neural network was constructed to evaluate whether the same biomarkers could classify vagus nerve CSA as within or outside the reference range. Results: Mean vagus nerve CSA was 1.32±0.30 mm2 on the right side and 1.20±0.28 mm2 on the left side. Inflammatory biomarkers were significantly associated with right vagus nerve CSA classified as outside the reference range in logistic regression, whereas no significant association was observed for the left vagus nerve. The regression model showed acceptable discriminative performance for the right vagus nerve (AUC=0.76, p=0.018). The exploratory neural network model showed similar classification performance. Conclusions: Systemic inflammatory biomarkers were associated with right vagus nerve CSA classified as outside the reference range on ultrasound, but not with left vagus nerve CSA, in hospitalised patients with COVID-19. These findings suggest a possible link between systemic inflammation and ultrasound-detectable variation in vagus nerve morphology. Larger studies are needed to confirm these findings and clarify their biological significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.